2024-08-06T12:42:32-05:00 2023-12-31 232896692 BBD LLP 1835 MARKET STREET SUITE 300 PHILADELPHIA PA 19103 990 2023-01-01 872975064 REMS INDUSTRY CONSORTIUM INC REMS 8563806894 1120 ROUTE 73 SUITE 200 MOUNT LAUREL NJ 08054 KEVIN HOLMAN CHAIRPERSON 8563806894 2024-08-06 1 0 ADAM WATSON P01367206 2155677770 2024-08-06 2023 2024-08-08 14:25:15Z KEVIN HOLMAN 1120 ROUTE 73 SUITE 200 MOUNT LAUREL NJ 08054 685242 0 X REMSCONSORTIUM.ORG X 2021 NJ IMPROVING PATIENT SAFETY AND MEDICATION ACCESS THROUGH REMS INNOVATION. 6 6 0 40 0 0 0 0 397500 685242 0 0 0 0 397500 685242 0 0 0 0 0 0 0 0 0 380567 589450 380567 589450 16933 95792 98502 151689 60270 17665 38232 134024 THE REMS INDUSTRY CONSORTIUM FOSTERS COLLABORATION AND INNOVATION TO ADVANCE PATIENT SAFETY, APPROPRIATE ACCESS, AND BEST PRACTICES IN REMS-RELATED DRUG AND BIOLOGIC RISK MANAGEMENT. 0 0 THE REMS INDUSTRY CONSORTIUM FOSTERS COLLABORATION AND INNOVATION TO ADVANCE PATIENT SAFETY, APPROPRIATE ACCESS, AND BEST PRACTICES IN REMS-RELATED DRUG AND BIOLOGIC RISK MANAGEMENT. 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 0 0 0 0 0 0 0 0 0 0 0 X 6 6 0 1 1 0 1 1 0 1 1 0 0 1 1 1 1 0 0 0 0 0 X THE ORGANIZATION 8563806894 1120 ROUTE 73 SUITE 200 MOUNT LAUREL NJ 08054 X KEVIN HOLMAN CHAIRPERSON 1.00 X X 0 0 0 KISHORE GOPU VICE CHAIRPERSON (FROM 5/18/23) 1.00 X X 0 0 0 SHERICE MILLS VICE CHAIRPERSON (UNTIL 4/20/23) 1.00 X X 0 0 0 KAL ELHOREGY TREASURER 1.00 X X 0 0 0 KISHORE GOPU SECRETARY (UNTIL 5/18/23) 1.00 X X 0 0 0 MICHAEL CHEUNG SECRETARY (FROM 5/18/23) 1.00 X X 0 0 0 MICHAEL CHEUNG BOARD MEMBER (UNTIL 5/18/23) 1.00 X 0 0 0 CHERIE JOHNSON BOARD MEMBER (FROM 12/1/23) 1.00 X 0 0 0 RON SELDERS BOARD MEMBER (FROM 5/18/23) 1.00 X 0 0 0 STEPHANIE STREIB BOARD MEMBER (4/20/23 - 12/1/23) 1.00 X 0 0 0 0 0 0 0 0 0 0 BUCHANAN INGERSOLL & ROONEY UNION TRUST BUILDING 501 GRANT ST PITTSBURGH PA 15219 MANAGEMENT SERVICES 380000 ASSOCIATION HEADQUARTERS INC 1120 ROUTE 73 SUITE 200 MOUNT LAUREL NJ 08054 MANAGEMENT COMPANY 117165 2 MEMBERSHIP DUES 541900 581500 581500 ANNUAL MEETING 900099 103742 49242 54500 685242 685242 630742 0 54500 360000 250 500 4902 2591 197138 8333 8729 BANK/CREDIT CARD FEES 3718 FILING FEES 1898 MISCELLANEOUS 701 TOOLS & SUBSCRIPTIONS 690 589450 20111 79197 61724 64159 25000 16667 16667 8333 98502 151689 270 60000 17665 60270 17665 X 38232 134024 38232 134024 98502 151689 95792 0 X 0 0 0 25000 16667 8333 8333 FORM 990, PART VI, SECTION A, LINE 3 THE ORGANIZATION RECEIVED VARIOUS MANAGEMENT SERVICES INCLUDING THOSE RELATED TO ADMINISTRATION, MEETINGS, ACCOUNTING AND WEBSITE SERVICES FROM ASSOCIATION HEADQUARTERS, INC. FORM 990, PART VI, SECTION A, LINE 4 (1) ESTABLISH THE NEW CATEGORY OF "INDUSTRY PARTNERS", AND (2) REVISE THE BYLAWS TO PERMIT MODIFICATION OF MEMBERSHIP CLASSES THROUGH A MAJORITY, RATHER THAN A SUPERMAJORITY, VOTE. NOTE: THE CHANGE FROM SUPERMAJORITY TO MAJORITY VOTE HAS NO IMPACT ON THE CURRENT BOARD COMPOSITION. IT IS EXPECTED, HOWEVER, THAT THIS REVISION WILL BE IMPORTANT TO ENABLE PROMPT BOARD ACTION ON PROPOSED REVISIONS TO MEMBERSHIP CLASSES (AND THEIR ASSOCIATED RIGHTS OR PRIVILEGES) ONCE THE SIZE OF THE BOARD IS EXPANDED. FORM 990, PART VI, SECTION A, LINE 6 CURRENTLY, TWO CLASSES OF MEMBERSHIPS ARE AUTHORIZED: VOTING AND NONVOTING. IT IS CONTEMPLATED THAT ANY ENTITY THAT IS A DRUG OR BIOLOGIC COMPANY SPONSOR WHICH (I) ENGAGES IN COMMERCIALIZING (OR DEVELOPING FOR COMMERCIALIZATION) FDA-APPROVED PHARMACEUTICAL OR BIOPHARMACEUTICAL PRODUCTS WHICH ARE (OR MAY BE) SUBJECT TO REMS, AND (II) SUPPORTS FURTHERING THE GOALS OF RIC, INCLUDING UNDERTAKING ACTIVITIES TO FURTHER THOSE GOALS, MAY BE ADMITTED TO VOTING MEMBERSHIP; AND THAT ANY ENTITY THAT SUPPORTS FURTHERING THE GOALS OF RIC WHICH DOES NOT MEET THE ABOVE CRITERIA MAY BE ADMITTED AS A NONVOTING MEMBER. FORM 990, PART VI, SECTION A, LINE 7A CURRENTLY, TWO CLASSES OF MEMBERSHIPS ARE AUTHORIZED: VOTING AND NONVOTING. IT IS CONTEMPLATED THAT ANY ENTITY THAT IS A DRUG OR BIOLOGIC COMPANY SPONSOR WHICH (I) ENGAGES IN COMMERCIALIZING (OR DEVELOPING FOR COMMERCIALIZATION) FDA-APPROVED PHARMACEUTICAL OR BIOPHARMACEUTICAL PRODUCTS WHICH ARE (OR MAY BE) SUBJECT TO REMS, AND (II) SUPPORTS FURTHERING THE GOALS OF RIC, INCLUDING UNDERTAKING ACTIVITIES TO FURTHER THOSE GOALS, MAY BE ADMITTED TO VOTING MEMBERSHIP; AND THAT ANY ENTITY THAT SUPPORTS FURTHERING THE GOALS OF RIC WHICH DOES NOT MEET THE ABOVE CRITERIA MAY BE ADMITTED AS A NONVOTING MEMBER. FORM 990, PART VI, SECTION B, LINE 11B A COMPLETE COPY OF FORM 990 IS PROVIDED TO THE BOARD PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS REVIEWED ANNUALLY BY THE BOARD OF DIRECTORS. EACH DIRECTOR OR OFFICER SHALL ANNUALLY COMPLETE A DISCLOSURE FORM IDENTIFYING ANY RELATIONSHIPS, POSITIONS, OR CIRCUMSTANCES IN WHICH HE OR SHE IS INVOLVED THAT IS BELIEVED COULD CONTRIBUTE TO A CONFLICT OF INTEREST. IN THE EVENT A CONFLICT IS IDENTIFIED, THE EXECUTIVE COMMITTEE WILL BE NOTIFIED TO REVIEW AND ASSESS THE CASE AND PROCEED IN ACCORDANCE WITH THE ORGANIZATION'S POLICY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, FINANCIAL STATEMENTS, AND FORMS 990 AVAILABLE TO THE PUBLIC UPON REQUEST.